Publikationen in Zusammenarbeit mit Forschern von University of Tokyo (3)

2023

  1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

2020

  1. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

    Journal of Thoracic Oncology, Vol. 15, Núm. 3, pp. 344-359

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine